These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12895299)

  • 1. Ras oncogene mutations in urine sediments of patients with bladder cancer.
    Buyru N; Tigli H; Ozcan F; Dalay N
    J Biochem Mol Biol; 2003 Jul; 36(4):399-402. PubMed ID: 12895299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
    Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
    J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique.
    Conejo JR; Parra T; Cantero M; Jiménez A; Granizo V; de Arriba G; Carballo F
    Clin Chem; 1998 Jul; 44(7):1570-2. PubMed ID: 9665446
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations.
    Levesque P; Ramchurren N; Saini K; Joyce A; Libertino J; Summerhayes IC
    Int J Cancer; 1993 Nov; 55(5):785-90. PubMed ID: 7902340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection.
    Rieger-Christ KM; Mourtzinos A; Lee PJ; Zagha RM; Cain J; Silverman M; Libertino JA; Summerhayes IC
    Cancer; 2003 Aug; 98(4):737-44. PubMed ID: 12910517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma.
    Saito S; Hata M; Fukuyama R; Sakai K; Kudoh J; Tazaki H; Shimizu N
    Int J Urol; 1997 Mar; 4(2):178-85. PubMed ID: 9179693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
    Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S
    Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method to reveal possible ras mutations in DNA of urinary sediment cells.
    Cristaudo A; Vivaldi A; Guglielmi G; Sensales G; Ottenga F
    J Environ Pathol Toxicol Oncol; 1997; 16(2-3):201-4. PubMed ID: 9276002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of primary bladder cancer by microsatellite analysis.
    Mao L; Schoenberg MP; Scicchitano M; Erozan YS; Merlo A; Schwab D; Sidransky D
    Science; 1996 Feb; 271(5249):659-62. PubMed ID: 8571131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
    Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
    Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
    Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
    Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism.
    Sugano K; Tsutsumi M; Nakashima Y; Yamaguchi K; Ohkura H; Kakizoe T; Sekiya T
    Int J Cancer; 1997 Aug; 74(4):403-6. PubMed ID: 9291429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
    Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
    Chen X; Zhang J; Ruan W; Huang M; Wang C; Wang H; Jiang Z; Wang S; Liu Z; Liu C; Tan W; Yang J; Chen J; Chen Z; Li X; Zhang X; Xu P; Chen L; Xie R; Zhou Q; Xu S; Irwin DL; Fan JB; Huang J; Lin T
    J Clin Invest; 2020 Dec; 130(12):6278-6289. PubMed ID: 32817589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population.
    Nanda MS; Sameer AS; Syeed N; Shah ZA; Murtaza I; Siddiqi MA; Ali A
    Urol J; 2010; 7(3):168-73. PubMed ID: 20845292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.